Compare PBLS & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBLS | NATL |
|---|---|---|
| Founded | N/A | 2023 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2026 | 2023 |
| Metric | PBLS | NATL |
|---|---|---|
| Price | $28.42 | $47.39 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $45.60 |
| AVG Volume (30 Days) | 545.1K | ★ 553.7K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.98 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,354,000,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | $162.21 |
| Revenue Growth | N/A | ★ 0.86 |
| 52 Week Low | $25.56 | $23.56 |
| 52 Week High | $33.65 | $48.50 |
| Indicator | PBLS | NATL |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 79.39 |
| Support Level | $26.96 | $43.51 |
| Resistance Level | $30.90 | $48.50 |
| Average True Range (ATR) | 2.39 | 0.63 |
| MACD | -0.05 | 0.36 |
| Stochastic Oscillator | 30.56 | 98.97 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.